Consequently, hCNTF has potential therapeutic applications not only in neurodegenerative diseases such as Amytropic Lateral Sclerosis (ALS) and Huntington’s disease (HD), but also in obesity and related type II diabetes. The gene discussed is CNTF; the disease is obesity due to melanocortin 4 receptor deficiency.